Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx (HEMO) Share Price

Price 1,600.00p on 18-09-2025 at 18:40:07
Change 10.00p 0.65%
Buy 1,600.00p
Sell 1,490.00p
Last Trade: Sell 10.00 at 1,490.396p
Day's Volume: 123,388
Last Close: 1,545.00p
Open: 1,600.00p
ISIN: GB00BQVXM815
Day's Range 1,445.00p - 1,725.00p
52wk Range: 0.876p - 1,790.00p
Market Capitalisation: £85.78m
VWAP: 1,568.65214p
Shares in Issue: 5.36m

Hemogenyx (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 10 1,490.396p Negotiated Trade
16:29:52 - 18-Sep-25
Buy* 201 1,594.00p Ordinary
16:29:13 - 18-Sep-25
Sell* 8 1,529.60p Ordinary
16:28:08 - 18-Sep-25
Buy* 20 1,600.00p Ordinary
16:27:30 - 18-Sep-25
Sell* 17 1,529.60p Ordinary
16:26:21 - 18-Sep-25
Buy* 68 1,594.00p Ordinary
16:26:07 - 18-Sep-25
Buy* 500 1,553.866p Suspected BUY Trade
16:22:22 - 18-Sep-25
Sell* 7 1,490.00p SI Trade
16:21:37 - 18-Sep-25
Sell* 4 1,490.00p SI Trade
16:21:37 - 18-Sep-25
Unknown* 0 1,600.00p SI Trade
16:21:37 - 18-Sep-25
See more Hemogenyx trades

Hemogenyx (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Sep 2025 (Wed) 1,480.00 1,790.00 1,355.00 1,535.00 309,740
16th Sep 2025 (Tue) 1,365.00 1,580.00 1,210.00 1,232.50 249,644
15th Sep 2025 (Mon) 990.00 1,350.00 990.00 1,335.00 297,576
12th Sep 2025 (Fri) 880.00 1,030.00 880.00 1,010.00 119,319
11th Sep 2025 (Thu) 800.00 910.00 800.00 921.00 91,532
10th Sep 2025 (Wed) 794.00 830.00 750.00 816.00 310,406
9th Sep 2025 (Tue) 930.00 930.00 712.00 731.00 155,818
8th Sep 2025 (Mon) 900.00 1,065.00 834.00 894.00 406,881
5th Sep 2025 (Fri) 560.00 850.00 560.00 758.00 285,664
4th Sep 2025 (Thu) 504.00 680.00 504.00 600.00 155,393
3rd Sep 2025 (Wed) 714.00 728.00 520.00 537.00 315,272
2nd Sep 2025 (Tue) 890.00 946.00 590.00 716.00 414,150
1st Sep 2025 (Mon) 600.00 990.00 556.00 910.00 724,757
29th Aug 2025 (Fri) 360.00 660.00 360.00 530.00 627,904
28th Aug 2025 (Thu) 312.00 370.00 310.00 345.00 288,960
27th Aug 2025 (Wed) 195.50 372.00 190.50 320.00 505,016
26th Aug 2025 (Tue) 168.50 198.00 168.50 187.50 270,504
25th Aug 2025 (Mon) 172.00 172.00 172.00 172.00 0
22nd Aug 2025 (Fri) 170.00 175.50 170.00 172.00 143,359
21st Aug 2025 (Thu) 165.50 173.50 165.50 169.75 52,082
20th Aug 2025 (Wed) 156.00 160.00 156.00 161.25 24,993
19th Aug 2025 (Tue) 156.00 159.50 156.00 157.75 23,978
18th Aug 2025 (Mon) 158.50 158.50 158.50 158.50 40,147
See more Hemogenyx price history

Hemogenyx (HEMO) Regulatory News

Date Source Headline
17th Sep 2025 7:00 am RNS Third Patient Safety
11th Sep 2025 7:00 am RNS-R Invitation to Participate at DCNY Summit
8th Sep 2025 7:00 am RNS Manufacturing Partnership with Made Scientific
5th Sep 2025 7:00 am RNS Exercise of Warrants and Issue of Equity
3rd Sep 2025 1:57 pm RNS Exercise of Warrants and Issue of Equity
1st Sep 2025 3:06 pm RNS Issue of convertible loan notes
29th Aug 2025 7:00 am RNS Result of Audit Tender
26th Aug 2025 11:44 am RNS Hemogenyx raises £570,000 and Director's Dealing
15th Aug 2025 7:00 am RNS Third Patient Treated with HG-CT-1 CAR-T Therapy
31st Jul 2025 7:00 am RNS Total Voting Rights
See more Hemogenyx regulatory news

Hemogenyx (HEMO) Share News

Hemogenyx shares jump as third patient treated for leukaemia form

17th Sep 2025 11:54

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia. Read More

Hemogenyx inks manufacturing partnership deal with Made Scientific

8th Sep 2025 16:27

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has agreed a manufacturing partnership with US-based cell therapy contract development and manufacturing organisation Made Scientific. Read More

Hemogenyx stock rises on GBP570,000 fundraise for Chimeric trials

26th Aug 2025 13:54

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it has raised funds to continue phase 1 clinical trials, through an off-market allotment to its chief executive officer. Read More

Hemogenyx Pharmaceuticals shares up as phase one trial progresses

15th Aug 2025 12:34

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said a third patient has been successfully treated under its phase one trial of its CAR-T cell therapy, HG-CT-1, for relapsed or refractory acute myeloid leukemia. Read More

SMALL-CAP WINNERS & LOSERS: Card Factory buys WH Smith's funkypigeon

29th Jul 2025 10:55

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

See more Hemogenyx news
FTSE 100 Latest
Value9,228.11
Change19.74

Login to your account

Forgot Password?

Not Registered